School of Medicine
Showing 1,051-1,100 of 1,160 Results
-
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMental illness is the greatest thief of human potential today. By harnessing the power of medicine, entrepreneurship, and technology, we can return that potential to the 2 billion people suffering around the world.
Brainstorm is the world's first academic laboratory dedicated to transforming mental health through innovation and entrepreneurship. -
Cristiana Vattuone, PhD
Clinical Research Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Vattuone is lead clinician and researcher for the Autism and Developmental Disorders Research Program in the Division of Child Psychiatry and Behavioral Sciences. Dr. Vattuone's expertise includes clinical and neuropsychological assessment of autism spectrum disorder and associated genetic conditions. Dr. Vattuone received her Ph.D. in Human Development and Psychology from the University of California, Los Angeles with specialized training in the implementation of evidence-based interventions. Dr. Vattuone’s research efforts focus on the early identification, diagnosis, and treatment of infants and toddlers with autism spectrum disorder, developmental trajectories, and the role of the family in supporting positive outcomes. Her dedication to research, treatment, and training continues at ADDRP to support individuals with autism spectrum disorder and their families.
-
Janani Venugopalakrishnan
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism spectrum disorders
-
Daniel Virtheim
Clinical Research Coordinator, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator
-
Sarina Volari
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsResearcher on hypnotically-induced near-death experiences
-
Allison Vreeland
Clinical Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Postdoctoral Scholar, PsychiatryBioDr. Allison Vreeland (she/her) is a licensed clinical psychologist specializing in working with children, teens, and families. Dr. Vreeland received her PhD in Clinical Psychological Science with a minor in Quantitative Studies at Vanderbilt University. She completed her predoctoral clinical internship in Child Psychology at UCSF with specialty training through the Child Trauma Research Program. She completed a research and clinical fellowship in the Immune Behavioral Health Clinic at Stanford University, where she focused her research efforts on examining neurological markers of patients diagnosed with pediatric acute neuropsychiatric syndrome (PANS). Clinically, Dr. Vreeland’s program of clinical care is focused on the delivery of evidence-based clinical interventions for individuals with anxiety, OCD, PANS/PANDAS, mood disorders, and behavioral challenges.
-
Masataka Wada
Postdoctoral Scholar, Psychiatry
BioDr. Masataka (he/him/his) is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.
His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Masataka is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.
Dr. Masataka's scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field. -
Lynn C. Waelde, Ph.D.
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioLynn C. Waelde, Ph.D. is an Adjunct Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Professor Emeritus in the Psychology Department at Palo Alto University. Dr. Waelde’s many collaborative publications address the impacts of traumatic events and ways to use mindfulness and meditation to promote resilience and recovery from stress and trauma. She founded and directed the Inner Resources Center which offered intervention groups and trainings to thousands of participants, clients, and therapists over the past 15 years. Dr. Waelde is the author of Mindfulness and Meditation in Trauma Treatment: The Inner Resources for Stress Program, published in 2022. She has taken a special interest in family caregivers and the Inner Resources for Stress program has been named a Best Practice by the Benjamin Rose Institute on Aging. She recently coauthored Family Caregiver Distress, which is forthcoming in 2023. She is on the editorial board of Journal of Traumatic Stress and an Associate Editor of Mindfulness.
-
Diane Elizabeth Wakeham
Clinical Research Coordinator Associate, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator Associate, INSPIRE Clinic, Psychiatry and Behavioral Sciences
-
Dennis Wall
Professor of Pediatrics (Clinical Informatics), of Biomedical Data Science and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsSystems biology for design of clinical solutions that detect and treat disease
-
Po Wang
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBipolar Disorders, Psychopharmacology, Treatment, Anticonvulsants, Mood stabilizers
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Julia Weinman
Affiliate, Psych/General Psychiatry and Psychology (Adult)
BioJulia Weinman, MS, MA is a doctoral research affiliate within the Department of Psychiatry and Psychology at the Stanford School of Medicine in the Neuropsychology, Mood and Anxiety Disorder, and Women's Mental Health Lab. She is a doctoral candidate, pursuing her PhD in clinical psychology at Palo Alto University. Her research focuses on interpersonal trauma, empowerment, and post-traumatic growth. Currently, she is working with Dr. Jennifer Keller on the Building Empowerment and Resilience (BEAR) program for adult women with histories of interpersonal trauma.
-
Aileen Whyte
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders. -
Leanne Williams
Vincent V.C. Woo Professor, Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and, by courtesy, of Psychology
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)
BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise on the effects of trauma across the lifespan. She provides clinical services for children, adolescents, adults, and families affected by trauma and other forms of anxiety and stress. Dr. Wilson also leads an active research program focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood. She is the Principal Investigator of GIRLTALK: We Talk, a longitudinal study funded by the National Institute of Child Health and Human Development (NICHD) that examines links from childhood violence exposure to dating violence and sexual risk in young women from low-income communities in Chicago. Dr. Wilson has authored or co-authored thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is on the editorial board of the Journal of Youth and Adolescence.
-
Shannon Wiltsey Stirman
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.